Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-24 @ 11:44 PM
NCT ID:
NCT00863551
Eligibility Criteria:
Inclusion Criteria:
* Male or female, 65-75 years of age without evidence of memory impairment
* Subject has overactive bladder symptoms but otherwise healthy
* Non-smoker (refrained from any tobacco usage, including smokeless tobacco, nicotine patches, etc., for 6 months prior to the screening visit)
* Weight within normal range
* Ability to follow study instructions and likely to complete all required visits
Exclusion Criteria:
* Residual urine within bladder greater than 4 ounces
* Moderate or severe memory impairment
* Bleeding disorder
* Blood-thinning agents
* Concurrent overactive bladder medication
* Concurrent dementia drugs: Aricept (donepezil), Namenda (memantine), Cognex (tacrine), Exelon (rivastigmine), Razadyne (galantamine), galantamine or similar drugs for dementia
* Chronic kidney failure
* Abdominal bypass surgery for obesity
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
75 Years
Study:
NCT00863551
Study Brief:
Protocol Section:
NCT00863551